In addition, CD4+ T cells in SLE show a marked imbalance between effector and regulatory subsets, with a dominance of pro-inflammatory Th1, Th17, and Tfh cells, which contribute to disease exacerbation [105,106] (Figure 2). Here, CD4 is linked to systemic lupus erythematosus.